Form 4: Metagenomi Director Bernales Acquires Stock Options
SEC Form 4 Filing
Director Sebastian Bernales acquired stock options for 78,636 shares of Metagenomi, Inc. on April 1, 2024.
Summary
- On April 1, 2024, Sebastian Bernales, a director of Metagenomi, Inc., acquired stock options for 78,636 shares.
- The exercise price of these options is $10.82 per share.
- The options vest over time, with 33.33% vesting on April 1, 2025, and the remainder vesting in 24 equal monthly installments thereafter, contingent upon continued service with the issuer.
- Following the transaction, Bernales directly owns 78,636 derivative securities.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock option grants, which is neither particularly positive nor negative. It reflects standard compensation practices.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for maintaining market confidence.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of stock option grant. |
| 04/01/2025 | First vesting date for 33.33% of the stock options. |
| 03/31/2034 | Expiration date of the stock options. |
| 04/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.